Crossject Société Anonyme (EPA: ALCJ)
France
· Delayed Price · Currency is EUR
1.978
+0.030 (1.54%)
Nov 22, 2024, 4:56 PM CET
Crossject Société Anonyme Revenue
Crossject Société Anonyme had revenue of 1.58M EUR in the half year ending June 30, 2024, a decrease of -46.75%. This brings the company's revenue in the last twelve months to 2.36M, down -67.23% year-over-year. In the year 2023, Crossject Société Anonyme had annual revenue of 3.87M, down -45.18%.
Revenue (ttm)
2.36M
Revenue Growth
-67.23%
P/S Ratio
34.66
Revenue / Employee
21.04K
Employees
105
Market Cap
84.68M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.87M | -3.19M | -45.18% |
Dec 31, 2022 | 7.06M | 583.00K | 9.00% |
Dec 31, 2021 | 6.48M | 1.64M | 33.77% |
Dec 31, 2020 | 4.84M | -58.27K | -1.19% |
Dec 31, 2019 | 4.90M | 2.46M | 100.57% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech S.A. | 2.74B |
bioMérieux S.A. | 3.81B |
Ipsen S.A. | 3.44B |
Eurofins Scientific SE | 6.72B |
Virbac SA | 1.34B |
Ramsay Générale de Santé SA | 5.01B |